Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4955a732acc86e366d958fb007fcfce |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5115 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5192 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5094 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1658 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-661 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5161 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5153 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
filingDate |
2014-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_952c6105fab79b45ff68e2ca7d63f35e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c581b2b34d35f0645c89e22bdcf7aa57 |
publicationDate |
2015-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2015149559-A1 |
titleOfInvention |
Pharmaceutical composition for anti-vascular diseases and anti-tumor and use thereof |
abstract |
The present invention provides a pharmaceutical composition for anti-vascular diseases and anti-tumor. The effective ingredients of said pharmaceutical composition comprise bleomycin antitumor antibiotics, adrenal glucocorticoid, adrenalin or pharmaceutically acceptable salts thereof in the mass ratio of (1-8): (2-5): (0.00005-0.001). The pharmaceutical composition provided by the present invention can be used to treat vascular diseases and tumor. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114558124-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113425886-A |
priorityDate |
2014-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |